Author

Mariam Ismail Hassan

Observed names: M Hassan, M. Hassan, Md Wahidul Hassan

Institution: Misr University for Science and Technology

Observed institutions: Misr University for Science and Technology, Islamic University, Insmed (United States)

ORCID: 0009-0000-2137-5029

Observed ORCID: 0009-0000-2137-5029

OpenAlex ID: A5113824220

A Study on Electrolyte Imbalance in Asphyxiated Neonates

2017 · Farhana Rahman, Md Abu Bakar Siddique, et al. · KYAMC Journal · 7

PDF

PCR140 Psychometric Validation of the QOL-B Respiratory Domain in Adults with Newly Diagnosed or Recurrent Mycobacterium avium Complex (MAC) Lung Disease: The ARISE and ENCORE Studies

2024 · KC Mange, D Serrano, et al. · Value in Health · 2

PDF

Change in Patient Reported Respiratory Symptoms in a Randomized, Double-blind, Trial of Amikacin Liposome Inhalation Suspension in Adults With Newly Diagnosed or Recurrent Mycobacterium Avium Complex Lung Disease: The ARISE Study

2024 · C.L. Daley, D. Serrano, et al. · American Journal of Respiratory and Critical Care Medicine · 2

Characteristics of frequent exacerbators in the US Bronchiectasis and NTM Research Registry (BRR)

2022 · N Lapinel, R Choate, et al. · European Respiratory Journal · 2

Identifying Potentially Undiagnosed Nontuberculous Mycobacterial Lung Disease Among Patients with Chronic Obstructive Pulmonary Disease: Development of a Predictive Algorithm Using Claims Data

2021 · P. Wang, T.K. Marras, et al. · American Journal of Respiratory and Critical Care Medicine · 2

PDF

Extracorporeal shock wave therapy versus Kinesio taping in treating musculoskeletal disorders: A GRADE-assessed systematic review and meta-analysis

2025 · Mariam Hesham Sallam, Marwa Shafiek Mustafa Saleh, et al. · Journal of Back and Musculoskeletal Rehabilitation · 1

Long-term Hospitalization Burden Among Patients With Chronic Obstructive Pulmonary Disease With Possible Diagnostic Delays of Nontuberculous Mycobacterial Lung Disease

2023 · P. Wang, T.K. Marras, et al. · American Journal of Respiratory and Critical Care Medicine · 1

The Hospitalization Burden Among Treatment-Refractory Nontuberculous Mycobacterial Lung Disease Patients in Japan

2022 · P. Wang, K. Morimoto, et al. · American Journal of Respiratory and Critical Care Medicine · 1

Incremental Mortality Associated with Nontuberculous Mycobacterial Lung Disease Among US Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease

2021 · P. Wang, T.K. Marras, et al. · American Journal of Respiratory and Critical Care Medicine · 1

PDF

Focused shock wave versus radial pressure wave therapy for musculoskeletal disorders: A systematic review and meta-analysis

2026 · Mariam Ismail Hassan, Ahmed Ibrahim Abdelhamed, et al. · Journal of Back and Musculoskeletal Rehabilitation

P93 A qualitative interview study to explore the use of adverse event mitigation strategies among adults receiving amikacin liposome inhalation suspension (ALIS) in real world settings

2023 · J Ali, J Wu, et al. · Thorax

PDF

A Qualitative Interview Study to Explore the Use of Adverse Event Mitigation Strategies Among Adults Receiving Amikacin Liposome Inhalation Suspension (ALIS) in Real World Settings

2023 · J. Ali, J. Wu, et al. · American Journal of Respiratory and Critical Care Medicine

Diminution des hospitalisations après le début d’un traitement par amikacine liposomale inhalée en suspension : étude de cohorte rétrospective en vie réelle

2023 · J. Wu, M. Hassan, et al. · Revue des Maladies Respiratoires Actualités

Reduction in Hospitalizations Following Initiation of Amikacin Liposome Inhalation Suspension: A Retrospective Cohort Study of Patients in Real-World Settings

2022 · J. Wu, M. Hassan, et al. · American Journal of Respiratory and Critical Care Medicine

Brensocatib for the Treatment of Non-Cystic Fibrosis Bronchiectasis (NCFBE): Number Needed to Treat (NNT) and Number Needed to Harm (NNH)

2022 · J.D. Chalmers, M.L. Metersky, et al. · American Journal of Respiratory and Critical Care Medicine

Pulmonary Exacerbations (PEx) and Hospitalizations in Commercially Insured Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE) Over 1- and 2-Year Follow-Up Periods

2022 · P.A. Flume, J. Feliciano, et al. · American Journal of Respiratory and Critical Care Medicine

ALIS (Amikacin Liposome Inhalation Suspension) for the Treatment of Patients with Refractory Mycobacterium avium Complex Lung Disease (MACLD) the Number Needed to Treat (NNT) and Number Needed to Harm (NNH)

2021 · T.K. Marras, M. Hassan, et al. · American Journal of Respiratory and Critical Care Medicine

PDF

Concurrent Randomized, Double-Blind, Placebo-Controlled Trials to Validate Patient-Reported Outcome (PRO) Instruments and Assess Clinical Benefit of Treatment in Adults with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium AviumComplex (MAC)

2021 · C.L. Daley, J.D. Chalmers, et al. · American Journal of Respiratory and Critical Care Medicine

PDF

Works count: 18

Citation count: 19

H-index: 2

I10-index: